Table 1.
Patients n = 82 | Median (range) | Postop. lymphatic leakage | n (%) |
Sex (n: ♀:♂) | 34:48 | None* | 21 (26) |
Age (years) | 60 (20–86) | Grade A | 11 (13) |
BMI (kg/m2) | 27 (18–47) | Grade B | 23 (28) |
Obesity | 22 (27) | Grade C | 27 (33) |
RILND indications | n (%) | Comorbidities | n (%) |
Melanoma | 71 (87) | Diabetes | 13 (16) |
Merkel cell carcinoma | 4 (5) | Smoker | 18 (27) |
Others: S (n = 2), AC (n = 2), PC (n = 2), EC (n = 2), NHL (n = 1) | 7 (8) | ||
Operative and drainage details | Median (range) | Postoperative morbidity | n (%) |
Duration of hospital stay | 10 (4–79) | Seroma | 29 (35) |
Duration of surgery (min) | 128 (27–302) | Needle aspiration | 12 (15) |
Duration of drainage (days) | 7 (1–30) | Reoperations | 26 (32) |
Drainage volume day 2 (ml) | 310 (45–1595) | Readmission | 17 (21) |
Drainage volume at removal (ml) | 90 (0–1000) | Delay of adjuvant therapy | 10 (12) |
AC anal cancer, EC esophageal cancer, NHL Non-Hodgkin lymphoma, PC prostate cancer, S sarcoma
*None equals Grade 0